The recognition of Chlamydia trachomatis as an important human pathogen has led to a greatly increased demand for laboratories to provide a diagnostic service for this organism. The current technique of isolation in cell culture is technically demanding and requires at least 48-72 hours for a result.
Solid phase enzyme linked immunoassays (ELISAs) have been described as ideal procedures for semiautomated mass screening tests. They have proved in some cases, however, to be insufficiently sensitive to replace culture, particularly when low numbers of micro-organisms are present, because they lack the multiplication of antigen inherent in a culture process.
We report the application of a novel enzyme amplification procedure used in the development and production of a rapid sensitive diagnostic test for C trachomatis.
In a conventional "sandwich" ELISA an enzyme-antibody conjugate reacts directly with a suitable substrate to give a coloured product. The enzyme amplified immunoassay differs from the conventional assay in that it has an amplification process in two stages and uses two separate enzyme systems. In the first of these the substrate nicotinamide adenine dinucleotide phosphate (NADP) is converted to nicotinamide adenine dinucleotide (NAD) by the action of alkaline phosAccepted for publication 11 June 1985 phatase conjugated to a monoclonal antibody. The subsequent addition of a secondary enzyme system permits the interconversion of NAD to its reduced form (NADH) by alcohol oxidoreductase. A second enzyme diaphorase regenerates the NAD (Figure) .
During this cyclical process one molecule of NAD triggers the production of many molecules of the coloured product, formazan, which greatly increases the sensitivity of the test. The amplification "gain" of such a system depends on the relative concentrations and activities of the enzyme used. The reagents used in this test have been standardised to achieve a gain of about 500 x. Details concerning a comparison between non-amplified and amplified procedures will be published elsewhere.' (Tables 3, 4 ). In view of this the five culture positive but enzyme amplified immunoassay, negative specimens from Nottingham were retested by enzyme amplified immunoassay together with the corresponding culture transport media. All the specimens in the enzyme amplified immunoassay transport medium again yielded negative results, but three of five of the culture transport media were positive by enzyme amplified immunoassay, two from specimens that gave >10 inclusions per coverslip but less than one inclusion per field and one from a specimen that gave one to 10 inclusions per coverslip.
Discussion
The results of this study showed that the enzyme amplified immunoassay described compared favourably with cell culture for the diagnosis of C trachomatis infections. The isolation rate from men (46%) is similar to that found in other studies using a sensitive culture method.3 The isolation rate from women (24%) is also comparable with that found by other workers4 for patients attending clinics for sexually transmitted diseases. The high overall specificity (99%) of the test is attributable to the use of a monoclonal antibody directed against genus specific lipopolysaccharide antigen.5 The sensitivity of 92% was adequate in a study in which numbers were small. This good correlation was due in part to the fact that the monoclonal antibody detects not only elementary bodies but also 
